Europe Electric Two-Wheeler Sharing Market is Fastest Growing and Demanding with CAGR of +35.0%


The Europe electric two-wheeler sharing market is estimated to grow to $597.2 million by 2025 at a 35.0% CAGR during the forecast period (2019–2025), owing to the technological advancements in sharing services, increasing concerns over greenhouse gas emissions, and worsening urban road congestion. Furthermore, convenience in using shared vehicles is one of the factors driving the market growth. Sharing services refer to a facility, in which electric two-wheelers are available for short-term rentals.

Based on vehicle, the European electric two-wheeler sharing market is classified into kick scooter and scooter. Among these, electric scooters, due to the availability of scooter sharing services in the region from the last five years, dominated the market in the historical period (2017–2018) and will continue to do so in the future as well. However, in the near future, the market for kick scooters is anticipated to witness faster growth, at a CARG of over 65.0%.

The European electric two-wheeler sharing sector players currently have huge growth opportunities due to the large investments made by top investors from across the globe. For example, in 2018, Atomico and the European Investors Index Ventures invested in two U.S. companies offering electric kick scooter sharing services, namely Neutron Holdings Inc. (Lime) and Bird Rides Inc., respectively. Index Ventures invested around $100 million in the Series B round of Bird, whereas Atomico did not share the amount it invested in Lime.

Request Sample
In 2017, Germany dominated the electric two-wheeler sharing market in Europe going by the total sharing rides taken in a year. However, in 2018, Spain held the largest market share in terms of volume as well as value, owing to fact that many major sharing service providers here massively increased their fleet, thereby leading to the market growth. This shows that this new form of transportation is gaining popularity all across the country. For instance, in Barcelona, many players have begun operations, as the scooter culture is quite prevalent in the city.  

Now, technological advancements are one of the major factors driving the growth of the electric two-wheeler sharing market in Europe. The domain is completely dependent on technology, which proves instrumental in taking the services within easy reach in every corner of a city at the time of requirement. The services are majorly availed via mobile apps, where users and providers get in touch with each other for parking vehicles, booking rides and even at the time of payment.

Furthermore, many technological innovations have been introduced with unique concepts to boost the electric two-wheeler sharing market in Europe. Technological innovations, such as the introduction of the internet of things (IOT) and cloud computing, are aiding in the growth of the domain. IOT in the fleet management system has proved beneficial for operating an electric two-wheeler sharing service, as it helps in optimizing the sharing process via efficient vehicle monitoring and tracking, route handling, and potential problem detecting from a remote location.

Hence, with technological innovations and the growing popularity of kick scooters in various cities of the continent, the electric two-wheeler sharing market in Europe is expected to grow.


Share:

Global Telemedicine Market is Expecting Worldwide Growth


The global telemedicine market was valued at $21.5 billion in 2017 and is projected to witness a CAGR of 14.8% during the forecast period 2018–2023. The major factors driving the market growth are rising healthcare costs, prevalence of chronic and lifestyle-associated diseases, government funding and grants, smartphone users, and need for remote patient monitoring in developing countries, and consistent need for improved healthcare services.

Learn More About this Report: http://bit.ly/2ppeoYm


Due to climate change and changing lifestyle and food habits, incidents of diseases are increasing. Since doctors or medical professionals cannot always be available or patients cannot always go to a healthcare center, telemedicine came into being. Telemedicine helps healthcare professionals diagnose, evaluate, and treat patients, who are far away, using telecommunication equipment, including audio and video devices. The telemedicine market is segmented by type, service, specialty and region. The service segment comprises the tele education, tele monitoring, teleconsulting, tele training, and others categories.

Among all services, tele monitoring services are expected to witness the highest CAGR, of 17.0%, during the forecast period. It involves remotely monitoring patients, who are unable to visit a clinic or hospital. Such patients can have a number of monitoring devices in their home, the data from which is communicated to their healthcare provider via mobile, telephone, broadband technology or cable network. It is an easy way to monitor patients and minimize their frequent visits to the clinic. Owing to the increasing use of home-monitoring devices and associated benefits, especially for heart patients, tele monitoring is expected to fuel the telemedicine market prosperity.

Looking at the growth of the sector, the key telemedicine market players have launched advanced products and technologies or entered into collaborations. For instance, in January 2018, Philips announced a partnership with American Well, a telehealth solution provider. This will help Philips in embedding American Well’s telehealth technology into several of its devices and apps. Citing a product launch example, in April 2018, AMD Global Telemedicine Inc. introduced OnDemand Visit, which allows healthcare organizations to increase their service offerings and engage patients in a convenient way. Further, it also offers a virtual medical visit via a computer or smartphone.

Owing to advanced technologies, new partnerships and growing need for remote monitoring services, the telemedicine market is forecasted to witness healthy growth.
Share:

U.S. Automotive Tire Market to Witness 5.4% CAGR in Near Future


One of the largest automotive markets in the world is that of the U.S. In 2018, the industry contributed 3.0% to the country’s gross domestic production (GDP). Several reasons, such as existence of a large consumer base, presence of a well-developed infrastructure, introduction of an open investment policy, availability of a highly skilled workforce, and provision of local and state incentives for vehicle adoption, are responsible for the steady growth of the automotive industry in the U.S. In addition to this, the country is home to many global automobile and associated component manufacturers. Due to these, the demand for tires in the country is on a considerable rise.

To receive a free sample copy of this report

A tire surrounds the wheel’s rim to transfer the vehicle’s load from the axle to the ground and provides traction on the surface traveled over. As per a research conducted by P&S Intelligence, the U.S. automotive tire market reached a value of $57.9 billion in 2018 and is predicted to grow at a CAGR of 5.4% in the coming years. Tires are used by all kinds of vehicles: passenger vehicle, light commercial vehicle, two-wheeler, and medium & heavy commercial vehicles. Among these, the demand for tires was created the most by passenger vehicles due to the increased sales of large pickup trucks in the U.S., in the recent years.

High tire replacement rate owing to increased vehicle life acting as a major market driver

The U.S. automotive tire market is majorly driven by the high tire replacement rate. Due to various technological advancements in recent years, the average lifespan of vehicles has increased significantly. At present, vehicles in the U.S. have a lifespan ranging between 13 and 17 years. Moreover, the average life of vehicles increased considerably from 10.2 years in 2010 to 11.5 years in 2018. Factors such as fierce market competition and stringent government regulations have contributed to the vehicle’s longevity and reliability over the years. A recent study in the U.S. shows that although Americans are increasingly buying pickup trucks and sport utility vehicles (SUVs), they are also retaining their old vehicles owing to the enhanced longevity of those vehicles. This is resulting in the high replacement rate of tires used in the vehicles in the country.

Development of advanced tires being viewed as a key trend in the market

With advancements in technology and increased penetration of vehicles, the demand for tires with low rolling resistance for improved fuel efficiency, enhanced grip for increased safety, and less wear and tear for enhanced durability has risen considerably. Thus, to meet the changing requirements of the end users, players in the automotive tire market are focusing on the innovation and development of advanced products. For instance, the development of ultra-high-performance tires has helped increase the overall speed and reliability of tires. An average high-performance tire has the ability to sustain a speed up to 270 km/h, whereas an ultra-high-performance tire achieves a maximum speed of 299 km/h. These tires are also suitable for driving over rough terrains and for travelling longer distances owing to their higher durability than other tires. Thus, the development of advanced tires is the key trend observed in the U.S. automotive tire market.

U.S. automotive tire market’s competitive landscape
Some of the major players operating in the U.S. automotive tire market are Michelin North America Inc., The Goodyear Tire & Rubber Company, Cooper Tire & Rubber Company, Continental Tire the Americas LLC, Pirelli & C. S.p.A., Hankook Tire Company Limited, Kumho Tire U.S.A. Inc., Bridgestone Americas Inc., Toyo Tire Corporation, and Yokohama Tire Corporation.

Share:

Infection Surveillance Solutions Market Analysis, Share and Forecast Report 2024

Infection is the invasion and multiplication of microorganisms such as viruses, bacteria and parasites that are not normally present within the human body. An infection may cause no symptoms and be hidden, or it may cause symptoms and be clinically visible. An infection may remain localized, or it may spread through the blood or lymphatic vessels to become systemic (present in the entire body).

The global infection surveillance solutions market is growing due to the emergence of diseases caused by microorganisms that were previously not known. The microorganisms living naturally within the body are not considered as infectious for example, bacteria that normally live within the mouth and intestine such as E. coli do not cause an infection to the body. Hospital associated infections such as urinary tract infection, surgical site infections and pneumonia are increasing due to the use of contaminated devices, patient clothing, and other materials used in hospitals and clinics. This has thus provoked healthcare professionals and hospitals to adopt infection surveillance solutions to identify possible infections during the time the patient remains in hospital, and to develop necessary preventive measures for the same. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sterile medical devices.

To Learn More About this Report: http://bit.ly/2PNvuLl
The growth in the global infection surveillance solutions market is expected to be mainly due to the increasing incidence of HAIs; policies introduced by government for preventing these HAIs; and increase in expenditure in healthcare sector. According to World Health Organization (WHO), 9.9% of the gross domestic product (GDP) of the world was spent on healthcare in 2014. Furthermore, cost-effectiveness, and redundancy of clinical data and the increase in number of surgeries drive the growth of infection surveillance solutions market.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=infection-surveillance-solutions-market

The introduction of cloud-based software into the infection surveillance solutions market and high growth in developing countries across Asia-Pacific and Latin America provide vast area of opportunities for players in the infection surveillance solutions market.

Various players in the infection surveillance solutions market are focusing on collaborating with other companies to expand their product and service offerings as well as introduction of new treatment methods into the infection surveillance solutions market.

Some of the other key players in global market are, Premier Inc., Baxter International Inc., Gojo Industries, Inc., Truven Health Analytics (An IBM Company), DEB Group Ltd., Hygreen, Inc., Atlas Medical Software, and RL Solutions.
Share:

Global Clinical Nutrition Market Estimate To Boost Growth In Demand By 2022

The global clinical nutrition market was valued at $39,339.4 million in 2015, and it is expected to grow at a CAGR of 5.4% during 2016 - 2022. The factors driving the growth of the global market include increasing geriatric population, high birth rate and high number of premature birth, surge in the number of victims of malnutrition receiving treatment, surging incidence of lifestyle associated disease, and increasing incidence of cancer and central nervous system diseases. Malnutrition is a widespread problem, affecting the lives of millions of people globally. It is a condition that occurs due to deficiency of essential nutrients in the body. In 2010, around 40% of all hospital patients globally were malnourished.

Clinical nutrition is the most efficient way to treat malnutrition and helps in avoiding associated costs. In Europe, around one-third of all hospital patients were malnourished in 2012. The increase in the number of victims of malnutrition globally, is expected to result in an increased usage of healthcare resource due to the longer stays in hospitals. As per an article of 2012, the malnutrition cost European government up to USD 237.0 billion a year; while the clinical nutrition accounted for about 2.5% of the cost involved with malnutrition.

The increasing incidence of cancer and central nervous system (CNS) diseases is driving the growth of the global enteral nutrition market. Enteral nutrition products are considered to be one of the best alternatives during the treatment of cancer and CNS diseases, to avoid nutrition deficiency in human body, for optimal functioning of various organs. Cancer can change the metabolism of nutrient uptake in patient’s body, therefore they require good nutrition. Cancer may lead to malnutrition and weight loss; therefore, patients are required continuous nutrient feeding. Enteral nutrition is one of the best solutions to the problem. According to the WHO, there were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 globally. The organization also reported that 57% (8 million) of new cancer cases, 65% (5.3 million) of the cancer deaths and 48% (15.6 million) of the 5-year prevalent cancer cases occurred in the less developed regions.

To receive a free sample copy of this report
In 2015, Asia-Pacific held the largest share in the global clinical nutrition market with 40.4% share. The region is anticipated to witness rapid growth during the forecast period. The increasing birth rate, along with growing geriatric population and high number of people with malnutrition is driving the growth of the clinical nutrition market in the region. The total number of people aged 65 years and above in Asia-Pacific was estimated at 288.0 million in 2010. This number is expected to reach 911.0 million by 2050. Additionally, the increasing number of malnutrition treatment cases in the region is expected to increase the demand for clinical nutrition products.

Moreover, with the increasing disposable income, increasing healthcare expenditure, and increasing awareness regarding nutrition is anticipated to fuel the growth of the Asia-Pacific clinical nutrition market. The different governments in the region are running awareness programs throughout these countries to encourage people for consuming nutritional diet. This would indirectly support the growth of the clinical nutrition market in the region.

Some of the major players operating in the global clinical nutrition market include Baxter International Inc., Abbott Laboratories, B. Braun Melsungen AG, Nestlé S.A., Groupe Danone, Mead Johnson Nutrition Company, Fresenius Kabi AG, and Perrigo Company Plc.
Share:

Razor Market to Observe Strong Development by 2024

Razor market is expected to reach $20.2 billion by 2024, registering a CAGR of 2.3% during the forecast period, the market is buoyed by several factors, predominantly by increasing focus toward men’s personal grooming, and rising disposable income of the population, especially residing in developing countries such as India and China, finds P&S Intelligence.

Insights on market segments
Based on type, global razor market is categorized into cartridge, disposable, electric, straight, and safety razors. Among these, cartridge razor category accounted for largest revenue share in 2018. Asia-Pacific (APAC) and Europe were the largest regions for cartridge razor market, wherein China, India, and Germany accounted for major demand. Increased marketing campaigns by companies is one of the major factors being observed in the market during 2014-2018. Apart from this, the ease of replacing blade is another factor for its high growth. Gillette’s cartridge razors were the most preferred choice by the consumers in the razor market.

On the basis of segment, the global razor market has been classified into mass, standard, and premium. Among these, the market for mass segment held the largest revenue share in the year 2018. Disposable razors, straight razors, and a hefty part of cartridge razors lie under mass segment. Moreover, most of these razors are cheap and easy to use which makes them the preferred choice for its mass consumer base. APAC is the largest market for mass products which can be attributed to the low per capita income of the countries including India, South Korea, Indonesia, and others.

Moreover, on the basis of razor blade type, the global razor market is segmented into stainless steel and carbon steel blades, of which stainless steel blades recorded the dominating share in the market. Carbon steel blades are prone to rust, while stainless steel blades are superior in terms of built quality. This is one of the major factors that the consumers are adopting the use of stainless steel blades over carbon steel blades. Also, women consumers are switching to stainless steel blades from plastic razors, since the stainless steel is used in safety razors, and lasts longer when compared to the other types.

To receive a free sample copy of this report


Increasing lucrative opportunities in rural market
In APAC, countries such as India, Sri Lanka, Australia, Vietnam, and Philippines have large population living in rural areas. For instance, in India, 66% of the total population lives in rural areas. Similarly, it has been recorded that approximately 31% Australian population lives in remote or rural areas. Consumers residing in rural areas of developing countries use cheap quality razors and blades.

Razor Market Competitiveness
The global razor market is highly competitive on a global basis, with the presence of large manufacturers operating globally, and new entrants attempting to disrupt the market competing for consumer acceptance and limited retail shelf space. Competition is based upon factors such as brand perception, product performance and innovation, customer service, and price.

In terms of revenue, the top three players in the global razor market includes The Procter & Gamble Company, Koninklijke Philips N.V., and Edgewell Personal Care Company. Apart from these players, other key players such as Harry’s Inc., Societe BIC S.A. (BIC), Supermax Limited, and Dorco Co. Ltd., are focusing on product innovation to gain higher market share.
Share:

Cell-Based Assays Market and its Growth Landscape for the Next Few Years

Cell-based assays are commonly used analytical tools to measure the cell proliferation, viability, cytotoxicity, production and screening of compounds. Owing to the rise in cases of chronic disorders and increasing inclination of the government organizations and private firms funding in the health sector, there has been a consistent high demand of new therapeutic drug discovery. In this regard, the cell-based assays have advantage over the conventional animal based models for drug discovery. Cell-based assays utilizes live cell models to investigate the cellular mechanism when exposed to external stimuli and provide precise information about the intracellular molecular targets required in drug discovery screening.  In contrary to the animal based methods, the resultant toxicity and safety measures in cell based assays are monitored at an early stage of an experiment, hence it reduces the additional cost that can be generated due to high failure rates if monitored at a later stage of an experiment. In combination to high-throughput screening techniques, cell- based assays have gained its interest in the area of research and development for primary as well as secondary screening. However, cell-based assay’s experimental instruments and kits are expensive and require high skilled professionals to conduct the procedures as the cost of experimental procedure is relatively high. This acts as one of the key restraining factors governing the cell-based assays markets.

To Lean More About this report: http://bit.ly/33acESt

The global cell-based assays market is anticipated to grow on account of rise in the incidence of chronic diseases, increasing public and private intervention in the area of research and development, inclination towards cell-based assays over traditional biochemical assays, and a sustained increase in the drug discovery activity. According to the Centers for Disease Control and Prevention, 7 out of ten causes of death were due to chronic ailments, in 2014. Additionally, the cell-based assay techniques have many advantages over conventional methodology. The continuous advancement in technological products under cell-based assay along with their cost effectiveness are the major drivers of the growth of global cell-based assays market.

Geographically, North America has been the largest region in the global cell-based assays market, mainly attributable to the high public and private funding in the research and development field of cell-based assays market. North America is expected to remain the largest market in the global market during the period 2017 – 2023, followed by the Europe. Asia-Pacific is expected to witness the highest growth during the forecast period with, countries such as China, Japan and India expected to be the growing centers of the cell-based assay market in the region.

Some of the major players operating in the global cell-based assays market include Merck KGaA, Becton, Dickinson and Company, Promega Corporation, Danaher Corporation, GE Healthcare, Thermo Fisher Scientific Inc., Cell Signaling Technology, Inc., BioTek Instruments Inc., Lonza Group, ProQinase GmbH, Charles River Laboratories Inc, Cisbio Bioassays, Miltenyi Biotec, Cell Biolabs, Inc.,  DiscoverX Corporation, BioAgilytix Labs., Enzo Life Sciences, Inc., Aurelia Bioscience Ltd., Selexis SA, and QGel SA.
Share:

Popular Posts

Blog Archive